Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study

There are limited reports on the safety of remdesivir for patients with severe kidney disease. We investigated the safety of remdesivir administration for COVID-19 patients with estimated glomerular filtration rate (eGFR) <30 mL/min. This single-center retrospective study was conducted between Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Umemura, Takumi, Mutoh, Yoshikazu, Mizuno, Takahito, Hagihara, Mao, Kato, Hideo, Yamada, Tetsuya, Ikeda, Yoshiaki, Mikamo, Hiroshige, Ichihara, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691069/
https://www.ncbi.nlm.nih.gov/pubmed/36421623
http://dx.doi.org/10.3390/healthcare10112299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691069/
https://www.ncbi.nlm.nih.gov/pubmed/36421623
http://dx.doi.org/10.3390/healthcare10112299

Ejemplares similares